On Friday, Teladoc Health Inc (NYSE: TDOC) opened lower -9.60% from the last session, before settling in for the closing price of $8.85. Price fluctuations for TDOC have ranged from $6.35 to $15.21 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -33.66% over the last five years. Company’s average yearly earnings per share was noted 80.62% at the time writing. With a float of $174.68 million, this company’s outstanding shares have now reached $176.61 million.
Teladoc Health Inc (TDOC) Insider Activity
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Teladoc Health Inc is 1.14%, while institutional ownership is 73.78%. The most recent insider transaction that took place on Oct 02 ’25, was worth 23,434. In this transaction Chief Accounting Officer of this company sold 2,972 shares at a rate of $7.88, taking the stock ownership to the 5,361 shares. Before that another transaction happened on Sep 11 ’25, when Company’s CHIEF EXECUTIVE OFFICER sold 16,787 for $7.59, making the entire transaction worth $127,435. This insider now owns 179,014 shares in total.
Teladoc Health Inc (TDOC) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.32) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 52.33% during the next five years compared to -33.66% drop over the previous five years of trading.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
Check out the current performance indicators for Teladoc Health Inc (TDOC). In the past quarter, the stock posted a quick ratio of 2.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.56. Likewise, its price to free cash flow for the trailing twelve months is 4.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.19, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.79 in one year’s time.
